AR106977A1 - Compuestos para el tratamiento de la enfermedad de alzheimer y/o la angiopatía amiloide cerebral - Google Patents
Compuestos para el tratamiento de la enfermedad de alzheimer y/o la angiopatía amiloide cerebralInfo
- Publication number
- AR106977A1 AR106977A1 ARP160103818A ARP160103818A AR106977A1 AR 106977 A1 AR106977 A1 AR 106977A1 AR P160103818 A ARP160103818 A AR P160103818A AR P160103818 A ARP160103818 A AR P160103818A AR 106977 A1 AR106977 A1 AR 106977A1
- Authority
- AR
- Argentina
- Prior art keywords
- amylooid
- angiopathy
- cerebral
- alzheimer
- disease
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Reivindicación 1: Un compuesto que tiene una estructura representada por la fórmula (1) ó (2), donde: R¹, R², R⁴ se seleccionan independientemente entre H, alquilo C₁₋₈, arilo, (CH₂)ₙ-arilo, (CH₂)ₙ-heteroarilo; n = 0 - 8; X¹, X² se seleccionan independientemente entre CO, SO, SO₂, -CONH-, SO₂NH-, SONH-; y A¹, A², B¹, B², C¹, C² se seleccionan independientemente entre H, OR⁴, F, con la salvedad de que el compuesto no es 2-acetamido-1,2-didesoxinojirimicina o 2-acetamido-1,2-didesoxigalactonojirimicina, o una de sus sales, solvatos o profármacos farmacéuticamente aceptables.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562266760P | 2015-12-14 | 2015-12-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR106977A1 true AR106977A1 (es) | 2018-03-07 |
Family
ID=59018347
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP160103818A AR106977A1 (es) | 2015-12-14 | 2016-12-13 | Compuestos para el tratamiento de la enfermedad de alzheimer y/o la angiopatía amiloide cerebral |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US9994589B2 (es) |
| EP (1) | EP3390408A1 (es) |
| JP (1) | JP2019502679A (es) |
| CN (1) | CN108368131A (es) |
| AR (1) | AR106977A1 (es) |
| AU (1) | AU2016371917A1 (es) |
| CA (1) | CA3008266A1 (es) |
| TW (1) | TW201725197A (es) |
| WO (1) | WO2017106288A1 (es) |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3722788A1 (de) * | 1987-07-10 | 1989-01-19 | Bayer Ag | Chirale 6-hydroxymethylenverzweigte 3-amino-4,5-dihydroxypiperidine, zwischenprodukte zu ihrer herstellung, verfahren zu ihrer herstellung und ihre verwendung |
| US5206251A (en) * | 1992-04-01 | 1993-04-27 | G. D. Searle & Co. | 2- and 3- amino and azido derivatives of 1,5-iminosugars |
| WO2010015816A2 (en) | 2008-08-06 | 2010-02-11 | Summit Corporation Plc | Treatment of lysosomal storage disorders and other proteostatic diseases |
| DK2490712T3 (en) | 2009-10-19 | 2015-10-05 | Amicus Therapeutics Inc | PROCESS FOR THE TREATMENT OF ALZHEIMER'S DISEASE BY USING Pharmacological chaperones TO INCREASE ACTIVITY OF GANGLIOSIDASER |
| PT2655388T (pt) * | 2010-12-23 | 2016-09-06 | Merck Sharp & Dohme | Inibidores de glicosidase seletivos e as suas utilizações |
| WO2012159262A1 (en) * | 2011-05-24 | 2012-11-29 | Alectos Therapeutics Inc. | Selective glycosidase inhibitors and uses thereof |
| MX364602B (es) * | 2011-06-27 | 2019-05-02 | Alectos Therapeutics Inc | Inhibidores selectivos de glicosidasa y usos de los mismos. |
| EP2890678A4 (en) * | 2012-08-31 | 2016-01-27 | Alectos Therapeutics Inc | GLYCOSIDASE INHIBITORS AND USES THEREOF |
| US9675627B2 (en) | 2014-04-14 | 2017-06-13 | Amicus Therapeutics, Inc. | Dosing regimens for treating and/or preventing cerebral amyloidoses |
-
2016
- 2016-12-13 AR ARP160103818A patent/AR106977A1/es unknown
- 2016-12-13 US US15/377,437 patent/US9994589B2/en active Active
- 2016-12-14 CA CA3008266A patent/CA3008266A1/en active Pending
- 2016-12-14 AU AU2016371917A patent/AU2016371917A1/en not_active Abandoned
- 2016-12-14 TW TW105141335A patent/TW201725197A/zh unknown
- 2016-12-14 CN CN201680073527.4A patent/CN108368131A/zh active Pending
- 2016-12-14 JP JP2018530696A patent/JP2019502679A/ja active Pending
- 2016-12-14 EP EP16820502.9A patent/EP3390408A1/en not_active Withdrawn
- 2016-12-14 WO PCT/US2016/066572 patent/WO2017106288A1/en active Application Filing
-
2018
- 2018-06-11 US US16/004,723 patent/US10174054B2/en active Active
-
2019
- 2019-01-07 US US16/241,215 patent/US10793583B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN108368131A (zh) | 2018-08-03 |
| CA3008266A1 (en) | 2017-06-22 |
| TW201725197A (zh) | 2017-07-16 |
| JP2019502679A (ja) | 2019-01-31 |
| US9994589B2 (en) | 2018-06-12 |
| AU2016371917A1 (en) | 2018-06-28 |
| US10793583B2 (en) | 2020-10-06 |
| US20170166588A1 (en) | 2017-06-15 |
| US10174054B2 (en) | 2019-01-08 |
| EP3390408A1 (en) | 2018-10-24 |
| US20190135832A1 (en) | 2019-05-09 |
| US20180291037A1 (en) | 2018-10-11 |
| WO2017106288A1 (en) | 2017-06-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1119585T1 (el) | Ενωσεις τετραϋδροπυρρολοθειαζινης | |
| CY1120705T1 (el) | Καινοφανεις αναστολεις αποακετυλασων ιστονων | |
| AR110400A1 (es) | Compuestos de amino-triazolopiridina y su uso en el tratamiento del cáncer | |
| BR112017006253A2 (pt) | novos compostos | |
| CY1120173T1 (el) | Ενωση πυραζολο-αμιδιου και φαρμακευτικες χρησεις αυτης | |
| CU24435B1 (es) | Compuesto de (pirazolilamino) pirimidinil biciclo (3.2.1)oct-8-il | |
| AR095339A1 (es) | Compuestos moduladores alostericos de la hemoglobina | |
| CY1119220T1 (el) | Μονοκυκλικο παραγωγο πυριδινης | |
| EA201692193A1 (ru) | Способы получения ингибитора jak1 и его новых форм | |
| CU24411B1 (es) | Compuesto derivado de benzamida sustituida con 1,3-tiazol-2-ilo útil para el tratamiento de trastornos neurogénicos | |
| AR101815A1 (es) | Compuestos y composiciones como inhibidores de quinasa | |
| CY1121626T1 (el) | Νεο παραγωγο υδροξαμικου οξεος ή αλας αυτου | |
| AR097082A1 (es) | Compuestos terapéuticamente activos y sus métodos de uso | |
| AR104415A1 (es) | Compuestos antiestrogénicos derivados de cromeno | |
| EA201991241A1 (ru) | Способ получения метоксиметилпиридин дикарбоксилата | |
| AR095523A1 (es) | Derivados piridin-4-ilo | |
| AR103742A1 (es) | Derivados de trifluorometilpropanamida | |
| EA201591915A1 (ru) | Соединения феноксиэтил дигидро-1h-изохинолина | |
| PE20190376A1 (es) | Combinaciones farmaceuticas para el tratamiento del cancer | |
| MX2016015247A (es) | Derivados de benceno-sulfonamida y su uso como moduladores del receptor c huerfano relacionado a acido retinoico (rorc). | |
| CL2017000484A1 (es) | Compuestos de azetidiniloxifenilpirrolidina | |
| AR095097A1 (es) | Compuestos de fenoxietoxi | |
| CL2020000376A1 (es) | Compuesto pentacíclico. | |
| MD3395821T2 (ro) | Compuși antitumorali | |
| AR101222A1 (es) | Derivados de piridona |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |